Transcriptional control of the cell cycle

Current Opinion in Cell Biology

Volumn 8, Issue 3, 1996, Pages 318-324

  Sánchez, Irma ^a   Dynlacht, Brian D ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE; DNA DIRECTED RNA POLYMERASE; DNA DIRECTED RNA POLYMERASE III; RETINOBLASTOMA PROTEIN; RNA POLYMERASE; TRANSCRIPTION FACTOR E2F;

CELL CYCLE; GENE ACTIVATION; GENE REPRESSION; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN PROTEIN INTERACTION; REVIEW; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

EID: 0343027284     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(96)80004-4     Document Type: Article

References (45)

1. Dyson N: pRb, p107 and the regulation of the E2F transcription factor. J Cell Sci 1994, Suppl 18:81-87.
2. Ginsberg D, Vairo B, Chittenden T, Xiao Z-X, Xu G, Wydner KL, DeCaprio JA, Lawrence JB, Livingston DM: E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes Dev 1994, 8:2665-2679.
3. Sardet C, Vidal M, Cobrinik D, Geng Y, Onufryk C, Chen A, Weinberg RA: E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc Natl Acad Sci USA 1995, 92:2403-2407.
4. Vairo G, Livingston DM, Ginsberg D: Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes Dev 1995, 9:869-881.
5. Hijmans EM, Voorhoeve PM, Beiersbergen RL, Vant Veer LJ, Bernard R: E2F-5, a new E2F family member that interacts with p130 in vivo. Mol Cell Biol 1995, 15:3082-3089.
6. Hiebert SW, Chellapan SP, Horowitz JM, Nevins JR: The interaction of pRb with E2F inhibits the transcriptional activiity of E2F. Genes Dev 1992, 6:177-185.
7. Zamanian M, LaThangue NB: Adenovirus E1a prevents the retinoblastoma gene product from repressing the activity of a cellular transcription factor. EMBO J 1992, 11:2603-2610.
8. Helin K, Harlow E, Fattaey AR: inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol Cell Biol 1993, 13:6501-6508.
9. Muller R: Transcriptional regulation during the mammalian cell cycle. Trends Genet 1995, 11:173-178.
10. 2 expression of the cdc2 gene. This element apparently binds the p130-E2F-4 complex, as detected by electrophoretic mobility shift assays, and loss of protection of the cdc2 promoter by this complex apparently results in induction of cdc2 gene expression, suggesting a distinct role for a particular E2F complex in transcriptional repression.
11. Wells J, Held P, Illenye S, Heintz NH: Protein-DNA interactions at the major and minor promoters of the divergently transcribed dhfr and rep3 genes during the Chinese hamster ovary cell cycle. Mol Cell Biol 1996, 16:634-647.
12. Lam EW-F, Watson JR: An E2F-binding site mediates cell cycle-regulated repression of mouse B-myb transcription. EMBO J 1993, 12:2705-2713.
13. Lam EW-F, Morris JDH, Davies R, Crook T, Watson RJ, Vousden KH: HPV16 E7 oncoprotein deregulates B-myb expression: correlation with targeting of p107/E2F complexes. EMBO J 1994, 13:871-878.
14. Johnson DG, Ohtani K, Nevins JR: Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. Genes Dev 1994, 8:1514-1525.
15. Zhu L, Zhu L, Xie E, Chang L-S: Differential roles of two tandem E2F sites in repression of the human p107 promoter by retinoblastoma and p107 proteins. Mol Cell Biol 1995, 15:3552-3562.
16. Lucibello FC, Truss M, Zwicker J, Ehlert F, Beato M, Muller R: Periodic cdc25C transcription is mediated by a novel cell cycle-regulated repressor element (CDE). EMBO J 1995, 14:132-142.
17. •] suggests that E2F complexes are involved.
18. Wang C-Y, Petryniak B, Thompson CB, Kaelin WG, Leiden JM: Regulation of the Ets-related transcription factor Elf-1 by binding to the retinoblastoma protein. Science 1993, 260:1330-1335.
19. Weintraub SJ, Chow KNB, Luo RX, Zhang SH, He S, Dean DC: Mechanism of active transcriptional repression by the retinoblastoma protein. Nature 1995, 375:812-815. These studies, which address the mechanisms by which pRb represses transcription, show that, in transfection experiments, recruitment of pRb to promoters by E2F results in the inhibition of adjacent trans-activators which are able to bind simultaneously to pRb. Thus, tethering pRb to the promoter resulted in repression of c-myc, Elf-1, and PU.1 bound proximally to an E2F site. In vitro binding experiments indicate that pRb may inhibit PU.1 activity by blocking the interaction between PU.1 and TFIID.
20. Sellers WR, Rodgers JW, Kaelin WG: A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites. Proc Natl Acad Sci USA 1995, 92:11544-11548.
21. Shao Z, Ruppert S, Robbins PD: The retinoblastoma-susceptibility gene product binds directly to the human TATA-binding protein associated factor TAF 250. Proc Natl Acad Sci USA 1995, 92:3115-3119.
22. Hagemeier C, Bannister AJ, Cook A, Kouzarides T: The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB. Proc Natl Acad Sci USA 1993, 90:1580-1584.
23. Rustgi AK, Dyson N, Bernards R: Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product Nature 1991, 352:541-544.
24. Gu W, Bhatia K, Magrath IT, Dang CV, Dalla-Favera R: Binding and suppression of the myc transcriptional activation domain by p107. Science 1994, 264:251-254.
25. Beijersbergen RL, Hijmans EM, Zhu L, Bernards R: Interaction of c-Myc with the pRb-related protein p107 results in inhibition of c-Myc mediated transactivation. EMBO J 1994, 13:4080-4086.
26. Singh P, Coe J, Hong W: A role for retinoblastoma protein in potentiating transcriptional activation by the glucocorticoid receptor. Nature 1995, 374:562-565. This work documents a potentially novel mechanism for pRb function that involves cooperation of pRb with the human SWI2-SNF2 homolog, hBrm, in glucocorticoid receptor mediated transcriptional activation.
27. Dunaief JL, Strober BE, Guha S, Khavari PA, Alin K, Luban J, Begemann M, Crabtree GR, Goff SP: The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest Cell 1994, 79:119-130.
28. Chen P-L, Riley DJ, Chen-Kiang S, Lee H-W: Retinoblastoma protein directly interacts with and activates the transcription factor NF-IL6. Proc Natl Acad Sci USA 1996, 93:465-469.
29. Kim S-J, Lee H-D, Robbins PD, Busam K, Sporn M, Roberts AB: Regulation of transforming growth factor β1 gene expression by the product of the retinoblastoma-susceptibility gene. Proc Natl Acad Sci USA 1991, 88:3052-3056.
30. Hunter T, Pines J: Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 1994, 79:573-582.
31. Dynlacht BD, Flores O, Lees JA, Harlow E: Differential regulation of E2F trsns-activation by cyclin/cdk2 complexes. Genes Dev 1994, 8:1772-1786.
32. Krek W, Ewen ME, Shirodkar S, Arany Z, Kaelin WG, Livingston DM: Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell 1994, 78:161-172.
33. Xu M, Sheppard KA, Peng C-Y, Yee AS, Piwnica-Worms H: Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation. Mol Cell Biol 1994, 14:8420-8431.
34. Koch C, Nasmyth K: Cell cycle regulated transcription in yeast Curr Opin Cell Biol 1994, 6:451-459.
35. 2 is provoked by the dissociation of SBF from promoters, presumably as a result of direct phosphorylation by Clb-Cdc28. The study raises interesting parallels between the regulation of a mammalian transcription factor (E2F) and a yeast transcription factor.
36. Cavanaugh AH, Hempel WM, Taylor LJ, Rogalsky V, Todorov G, Rothblum LI: Activity of RNA polymerase I transcription factor UBF blocked by Rb gene product Nature 1995, 374:177-180. A second potential mechanism of growth inhibition by pRb is uncovered, whereby pol I transcription is repressed, presumably through the ability of the tumor suppressor to bind the pol I auxiliary factor UBF and hence interfere with interactions between UBF and pol I. These findings suggest common mechanisms of repression of pol I and pol II transcription by pRb.
37. Gottesfeld JM, Wolf VJ, Dang T, Forbes DJ, Hartl P: Mitotic repression of RNA polymerase III transcription in vitro mediated by phosphorylation of a TFIIIB component Science 1994, 263:81-84.
38. Martinez-Balbas MA, Dey A, Rabindran SK, Ozato K, Wu C: Displacement of sequence-specific transcription factors from mitotic chromatin. Cell 1995, 83:29-38. Using in vivo footprinting and immunostaining, the authors suggest that the exclusion of sequence-specific transcription factors from mitotic chromatin could account for the global reduction in transcriptional activity during this phase of the cell cycle.
39. Liao S-M, Zhang J, Jeffery DA, Koleske AJ, Thompson CM, Chao DM, Viljoen M, Van Vuuren HJJ, Young RA: A kinase-cyclin pair in the RNA polymerase II holoenzyme. Nature 1995, 374:193-196. In this study, the authors have isolated two new components of the yeast RNA polymerase II holoenzyme, namely SRB10 and SRB11. Interestingly, the two proteins share significant homology with the mammalian Cdk8 and cyclin C proteins (see [40]), and yeast strains deficient for the kinase SRB10-SRB11 exhibit a reduced ability to phosphorylate the carboxy-terminal domain of pol II and a defective transcriptional response to galactose induction in vivo. However, the mutant form of the holoenzyme did not display defects in a reconstituted in vitro transcription assay.
40. Tassan J-P, Jaquenoud M, Leopold P, Schultz SJ, Nigg EA: Identification of human cyclin-dependent kinase 8, a putative protein kinase partner for cyclin C. Proc Natl Acad Sci USA 1995, 92:8871-8875.
41. Udvadia AJ, Rogers KT, Higgins PDR, Murata Y, Martin KH, Humphrey PA, Horowitz JM: Sp1 binds promoter elements regulated by the RB protein and Sp1-mediated transcription is stimulated by RB coexpression. Proc Natl Acad Sci USA 1993, 90:3265-3269.
42. Chen LI, Nishinaka T, Kwan K, Kitabayashi I, Yokoyama K, Fu Y-HF, Grunwald S, Chiu R: The retinoblastoma gene product RB stimulates Sp1-mediated transcription by liberating Sp1 from a negative regulator. Mol Cell Biol 1994, 14:4380-4389.
43. Gu W, Schneider JW, Condorelli G, Kaushal S, Mahdavi V, Nadal-Ginard B: Interaction of myogenic factors and the retinobiastoma protein mediates muscle cell commitment and differentiation. Cell 1993, 72:309-324.
44. lavarone A, Garg P, Lasorella A, Hsu J, Israel MA: The helix-loop-helix protein Id-2 enhances cell proliferation and binds to the retinoblastoma protein. Genes Dev 1994, 8:1270-1284.
45. Kim S-J, Wagner S, Liu F, O'Reilly MA, Robbins PD, Green MR: Retinoblastoma gene product activates expression of the human TGF-β2 gene through transcription factor ATF-2. Nature 1992, 358:331-334.